Zobrazeno 1 - 10
of 3 023
pro vyhledávání: '"advanced ovarian cancer"'
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5630-5642 (2024)
Background: Extensive surgery on advanced-stage epithelial ovarian cancer is associated with increased postoperative morbidity, which may cause a delay in or omission of chemotherapy. We examined postoperative complications and their effects on adjuv
Externí odkaz:
https://doaj.org/article/4ea564298dcf4c51b33e788314e59995
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 63, Iss 5, Pp 709-716 (2024)
Objective: This study presents the development and validation of a nomogram aimed at predicting platinum-sensitivity and survival outcomes in women with advanced epithelial ovarian cancer (EOC). Materials and methods: Data from a retrospective cohort
Externí odkaz:
https://doaj.org/article/1661632d30cd4cf188a402029679b26a
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe newest clinical evidence that the relationship between the peritoneal cancer index (PCI) and the postoperative prognosis of advanced ovarian cancer patients remains controversial, and there are no large-sample and multicenter studies to
Externí odkaz:
https://doaj.org/article/33de99c44e874a459f78c132a05f8640
Autor:
Viktoriia V. Yevsieieva, Volodimyr I. Cherniy, Kateryna V. Kharchenko, Yuriy B. Lisun, Ludmila M. Polukhovich
Publikováno v:
Клінічна та профілактична медицина, Iss 7, Pp 29-38 (2023)
Introduction. One of the main factors affecting postoperative outcomes in patients with advanced ovarian cancer is the cardiopulmonary status. Several studies have reported that preoperative multifactorial rehabilitation and physical fitness can lead
Externí odkaz:
https://doaj.org/article/01d48f7b36e54b0f87efc9ff3bc7891c
Autor:
Antoni Llueca, Sarai Canete-Mota, Anna Jaureguí, Manuela Barneo, Maria Victoria Ibañez, Alexander Neef, Enrique Ochoa, Sarai Tomas-Perez, Josep Mari-Alexandre, Juan Gilabert-Estelles, Anna Serra, Maria Teresa Climent, Carla Bellido, Nuria Ruiz, Blanca Segarra-Vidal, Maria Llueca
Publikováno v:
Diagnostics, Vol 14, Iss 17, p 1868 (2024)
Introduction: Ovarian cancer is the third most common gynaecological cancer and has a very high mortality rate. The cornerstone of treatment is complete debulking surgery plus chemotherapy. Even with treatment, 80% of patients have a recurrence. Circ
Externí odkaz:
https://doaj.org/article/d920c7fe1e9b41dfb1726a1e69eb767d
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-10 (2023)
Abstract Introduction In 2023, the final PAOLA-1 trial (NCT02477644) survival data were published documenting the benefits of therapy consisting of olaparib plus bevacizumab for patients with advanced ovarian cancer (AOC) as a function of molecular s
Externí odkaz:
https://doaj.org/article/1d037a54e3804944b56f92daba9305ba
Autor:
Bobbie J. Rimel, Dana M. Chase, Jessica Perhanidis, Armen A. Ghazarian, Ella Xiaoyan Du, Travis Wang, Jinlin Song, Amanda K. Golembesky, Jean A. Hurteau, Linda Kalilani, Ritu Salani, Bradley J. Monk
Publikováno v:
Gynecologic Oncology Reports, Vol 51, Iss , Pp 101332- (2024)
Poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors (PARPi) are metabolized either via carboxylesterase (niraparib) or cytochrome P450 (CYP) enzymes (olaparib and rucaparib). Patients with advanced epithelial ovarian cancer (aOC) who recei
Externí odkaz:
https://doaj.org/article/24bc1740259343c6a807b2eb7818b81b
Publikováno v:
BMC Surgery, Vol 23, Iss 1, Pp 1-5 (2023)
Abstract Background There have been no studies concerning the complications or benefits of cholecystectomy in ovarian cancer. In this study, we aimed to evaluate the outcomes of cholecystectomy performed during various time periods of the disease cou
Externí odkaz:
https://doaj.org/article/ab21cdd6741843cebf0da126d1391f29
Autor:
Matteo Generali, Gianluca Annunziata, Debora Pirillo, Giovanni D’Ippolito, Gino Ciarlini, Lorenzo Aguzzoli, Vincenzo Dario Mandato
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
ObjectivesThe aim of this narrative review is to summarize the available evidence on the use of minimal invasive surgery (MIS) in the management of epithelial ovarian cancer (EOC).BackgroundMIS is currently performed to stage and treat EOC at differe
Externí odkaz:
https://doaj.org/article/b11b37493841470ab7deae6daa4c687f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.